These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2236160)

  • 1. Modelling the effect of chemotherapy intensity.
    Coppin C; Coldman A; Goldie J
    Prog Clin Biol Res; 1990; 354B():103-16. PubMed ID: 2236160
    [No Abstract]   [Full Text] [Related]  

  • 2. Rationale for the use of alternating non-cross-resistant chemotherapy.
    Goldie JH; Coldman AJ; Gudauskas GA
    Cancer Treat Rep; 1982 Mar; 66(3):439-49. PubMed ID: 7060033
    [No Abstract]   [Full Text] [Related]  

  • 3. Integrating the concept of dose intensity into a strategy for systemic therapy of malignant disease.
    Hryniuk WM
    Prog Clin Biol Res; 1990; 354B():93-101. PubMed ID: 2236177
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dose intensity in cancer chemotherapy: definition, average relative dose intensity and effective dose intensity].
    Alberto P
    Bull Cancer; 1995; 82 Suppl 1():3s-8s. PubMed ID: 7626852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of dose-response relationships in the setting of high-dose ifosfamide, carboplatin, and etoposide and autologous hematopoietic stem cell transplantation: implications for the treatment of patients with advanced breast cancer.
    Perkins JB; Effenbein GJ; Fields KK
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):42-6. PubMed ID: 8677448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dose-effect of chemotherapy in bronchial small-cell cancer].
    de Crevoisier R; le Cesne A; le Chevalier T
    Rev Mal Respir; 1997 Sep; 14(4):269-75. PubMed ID: 9411610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of 1 and 25 Hz, 1.5 mT magnetic fields on antitumor drug potency in a human adenocarcinoma cell line.
    Ruiz-Gómez MJ; de la Peña L; Prieto-Barcia MI; Pastor JM; Gil L; Martínez-Morillo M
    Bioelectromagnetics; 2002 Dec; 23(8):578-85. PubMed ID: 12395412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of dose intensity in the outcome of chemotherapy.
    Hryniuk WM
    Important Adv Oncol; 1988; ():121-41. PubMed ID: 3042601
    [No Abstract]   [Full Text] [Related]  

  • 9. Dose intensity correlate with survival in elderly patients treated with chemotherapy for advanced non-small cell lung cancer.
    Luciani A; Bertuzzi C; Ascione G; Di Gennaro E; Bozzoni S; Zonato S; Ferrari D; Foa P
    Lung Cancer; 2009 Oct; 66(1):94-6. PubMed ID: 19171407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dose individualization for carboplatin in cancer chemotherapy].
    Oudard S; Lauraine EP
    Bull Cancer; 1997 Jun; 84(6):675-7. PubMed ID: 9295872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of likely cancer cure using first- and second-order product densities of population balance models.
    Sherer E; Hannemann RE; Rundell A; Ramkrishna D
    Ann Biomed Eng; 2007 Jun; 35(6):903-15. PubMed ID: 17440813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-agent chemotherapy of a solid murine tumor assayed by growth delay and cell survival.
    Begg AC; Fu KK; Kane LJ; Phillips TL
    Cancer Res; 1980 Jan; 40(1):145-54. PubMed ID: 7349894
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dose intensity of chemotherapy in small-cell lung carcinoma. Review of comparative studies].
    Sanz Rubiales A; del Valle Rivero ML; Garavís Vicente M; Rey Castro P; López-Lara Martín F
    An Med Interna; 2000 Jul; 17(7):378-85. PubMed ID: 10981338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mechanistic, predictive model of dose-response curves for cell cycle phase-specific and -nonspecific drugs.
    Gardner SN
    Cancer Res; 2000 Mar; 60(5):1417-25. PubMed ID: 10728708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of modelling chemotherapy-induced hematological toxicity for clinical practice.
    Testart-Paillet D; Girard P; You B; Freyer G; Pobel C; Tranchand B
    Crit Rev Oncol Hematol; 2007 Jul; 63(1):1-11. PubMed ID: 17418588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [General principles of dose-effect relationship].
    Borg C; Trillet-Lenoir V
    Bull Cancer; 2001 Sep; 88(9):833-4. PubMed ID: 11604354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dose intensity in cancer chemotherapy (including high dose chemotherapy)].
    Ariyoshi Y; Ogawa M
    Gan To Kagaku Ryoho; 1994 Dec; 21(16):2699-707. PubMed ID: 7993104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Average relative dose intensity and the impact on design of clinical trials.
    Hryniuk WM
    Semin Oncol; 1987 Mar; 14(1):65-74. PubMed ID: 3823917
    [No Abstract]   [Full Text] [Related]  

  • 19. A two-stage stepwise estimation procedure.
    Chen JT
    Biometrics; 2008 Jun; 64(2):406-12. PubMed ID: 18325070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between the IC(50), toxic threshold, and the magnitude of stimulatory response in biphasic (hormetic) dose-responses.
    Nascarella MA; Calabrese EJ
    Regul Toxicol Pharmacol; 2009 Aug; 54(3):229-33. PubMed ID: 19393280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.